Woldemichael et al. found carminomycin I as an effective inhibitor of VHL defective (VHL−/−) clear cell renal cell carcinoma (CCRCC) cell proliferation and the P-gp mediated localization of carminomycin I in CCRCC cells [41]. Here, VHL is linked to nonpapillary renal cell carcinoma.